- Cellular Analysis
- Flow Cytometry
- Haemoglobinopathies
- Haemostasis
- Molecular Diagnostics
- Morphology
- Platelets
- Point-of-Care Testing
- Standards and Quality Assurance
- Thrombosis
- Allergo Oncology
- Anticancer Drug Discovery
- Breast cancer
- Cancer Biomarkers
- Cancer Chemotherapy
- Cancer Epidemiology and Prevention
- Cancer Nursing and Integrative Medicine
- Cancer Related Policy and Public Health
- Chemotherapeutic agents
- Chemotherapy and radiotherapy
- Diagnosis and Prognosis of Cancers
- End of life care
- Radiation Oncology
- Clinical and medical Oncology
- Surgical Oncology
- Gynecologic Oncology
- Geriatric Oncology
- Pediatric Oncology
- Tumor Immunology and Immuno-Oncology
- Urologic Oncology
- Veterinary Oncology
- Targeted Cancer Treatments
- Malignancies and Immunosuppression
- Cancer Genomics and Metabolomics
- Cancer Biomarkers
- Organ Specific Cancers
- Immunotherapy
- Oral and Throat Cancers
- Melanoma and therapeutics
- Cancer Genetics and Epidemiology
- Cancer Bioinformatics
- Cancer Screening and Diagnosis
- Reproductive Cancers
- Tumor Metabolism and Pathology
- Novel Screening and Prevention techniques
- Anticancer Therapy - Detection and Delivery
- Palliative Care
- Red Cell Biology
- Blood Transplantation
- Hemoglobinopathies
- Epigenetic mechanisms
- Blood Disorders
- Lymphoid malignancies
- Pediatric Hematology
- Myeloid malignancies
- Bleeding and clotting disorders
IMPORTANT DATES
- Paper Submission (Full Paper)29th Nov, 2024
- Final Authors' Registration06th Dec, 2024
- Conference Dates
21st -
Dec, 2024
